Therapy-related myeloid neoplasms following chimeric antigen receptor T-cell therapy for Non-Hodgkin Lymphoma

Blood Cancer J. 2022 Jul 26;12(7):113. doi: 10.1038/s41408-022-00707-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell- and Tissue-Based Therapy
  • Humans
  • Immunotherapy, Adoptive / adverse effects
  • Lymphoma, Non-Hodgkin* / therapy
  • Receptors, Chimeric Antigen* / genetics

Substances

  • Receptors, Chimeric Antigen